| Bayside Health And Rehabilitation Center | |
| 4343 Langley Avenue, Pensacola, Florida 32504 | |
| (850) 477-4550 | |
| Name | Bayside Health And Rehabilitation Center |
|---|---|
| Location | 4343 Langley Avenue, Pensacola, Florida |
| Certified By | Medicare and Medicaid |
| No. of Certified Beds | 120 |
| Occupancy Rate | 89.92% |
| Medicare ID (CCN) | 105267 |
| Legal Business Name | Fl Hud Bayside, Llc |
| Ownership Type | For Profit - Corporation |
| NPI Number | 1255323143 |
| Organization Name | DELTA HEALTH GROUP INC |
| Doing Business As | BAYSIDE MANOR |
| Address | 4343 Langley Ave, Pensacola, FL 32504 |
| Phone Number | 850-477-4550 |
News Archive
HighRes Biosolutions, the leader in laboratory automation solutions for life science applications, announced today that it has selected Tekon Biotech Ltd., a leading full-service distributor to analytical and research laboratories, as exclusive distributor of its uniquely modular automation technologies to the top laboratories of China, Hong Kong and Taiwan.
Human Genome Sciences announced that BENLYSTA™ met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA™ has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.
Nutritionists have since joined with manufacturers to produce supplements using fermentation from this rare mushroom. One such product is CordyMax®, made with a formula recognized in China as the fermented Cordyceps mushroom mycelial product. CordyMax® has been placed under intellectual property protection, and only one company has the license for it outside of China.
› Verified 2 days ago
| NPI Number | 1437319258 |
| Organization Name | FL HUD BAYSIDE, LLC |
| Doing Business As | BAYSIDE HEALTH AND REHABILITATION CENTER |
| Address | 4343 Langley Avenue, Pensacola, FL 32504 |
| Phone Number | 850-477-4550 |
News Archive
HighRes Biosolutions, the leader in laboratory automation solutions for life science applications, announced today that it has selected Tekon Biotech Ltd., a leading full-service distributor to analytical and research laboratories, as exclusive distributor of its uniquely modular automation technologies to the top laboratories of China, Hong Kong and Taiwan.
Human Genome Sciences announced that BENLYSTA™ met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA™ has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.
Nutritionists have since joined with manufacturers to produce supplements using fermentation from this rare mushroom. One such product is CordyMax®, made with a formula recognized in China as the fermented Cordyceps mushroom mycelial product. CordyMax® has been placed under intellectual property protection, and only one company has the license for it outside of China.
› Verified 2 days ago
| NPI Number | 1629722830 |
| Organization Name | BAYSIDE MANOR OPERATING INVESTMENTS LLC |
| Address | 4343 Langley Ave, Pensacola, FL 32504 |
| Phone Number | 954-300-3878 |
News Archive
HighRes Biosolutions, the leader in laboratory automation solutions for life science applications, announced today that it has selected Tekon Biotech Ltd., a leading full-service distributor to analytical and research laboratories, as exclusive distributor of its uniquely modular automation technologies to the top laboratories of China, Hong Kong and Taiwan.
Human Genome Sciences announced that BENLYSTA™ met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA™ has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.
Nutritionists have since joined with manufacturers to produce supplements using fermentation from this rare mushroom. One such product is CordyMax®, made with a formula recognized in China as the fermented Cordyceps mushroom mycelial product. CordyMax® has been placed under intellectual property protection, and only one company has the license for it outside of China.
› Verified 2 days ago
| Ratings from Surveys (Inspections): | |
| Ratings from Quality Measures: | |
| Ratings from Staffing Data: | |
| Overall Rating: |
|---|
News Archive
HighRes Biosolutions, the leader in laboratory automation solutions for life science applications, announced today that it has selected Tekon Biotech Ltd., a leading full-service distributor to analytical and research laboratories, as exclusive distributor of its uniquely modular automation technologies to the top laboratories of China, Hong Kong and Taiwan.
Human Genome Sciences announced that BENLYSTA™ met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA™ has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.
Nutritionists have since joined with manufacturers to produce supplements using fermentation from this rare mushroom. One such product is CordyMax®, made with a formula recognized in China as the fermented Cordyceps mushroom mycelial product. CordyMax® has been placed under intellectual property protection, and only one company has the license for it outside of China.
› Verified 2 days ago
| Number of Facility Reported Incidents | 0 |
| Number of Substantiated Complaints | 0 |
| Number of Fines | 1 |
| Total Amount of Fines in Dollars | $300315 |
| Number of Payment Denials | 0 |
| Total Number of Penalties | 1 |
| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percentage of long-stay residents whose need for help with daily activities has increased | 17 | 14.46 |
| Percentage of long-stay residents who lose too much weight | 15.06 | 5.51 |
| Percentage of low risk long-stay residents who lose control of their bowels or bladder | 43.59 | 48.41 |
| Percentage of long-stay residents with a catheter inserted and left in their bladder | 2.03 | 1.79 |
| Percentage of long-stay residents with a urinary tract infection | 0.3 | 2.65 |
| Percentage of long-stay residents who have depressive symptoms | 3.98 | 5.05 |
| Percentage of long-stay residents who were physically restrained | 0 | 0.23 |
| Percentage of long-stay residents experiencing one or more falls with major injury | 5.19 | 3.36 |
| Percentage of long-stay residents assessed and appropriately given the pneumococcal vaccine | 98.96 | 93.87 |
| Percentage of long-stay residents who received an antipsychotic medication | 12.05 | 14.2 |
| Percentage of short-stay residents assessed and appropriately given the pneumococcal vaccine | 89.81 | 83.88 |
| Percentage of short-stay residents who newly received an antipsychotic medication | 1.32 | 1.79 |
| Percentage of long-stay residents whose ability to move independently worsened | 29.86 | 17.09 |
| Percentage of long-stay residents who received an antianxiety or hypnotic medication | 25.83 | 19.7 |
| Percentage of high risk long-stay residents with pressure ulcers | 12.68 | 7.32 |
| Percentage of long-stay residents assessed and appropriately given the seasonal influenza vaccine | 99.77 | 95.98 |
| Percentage of short-stay residents who made improvements in function | 75.17 | 67.99 |
| Percentage of short-stay residents who were assessed and appropriately given the seasonal influenza vaccine | 92.84 | 82.93 |
News Archive
HighRes Biosolutions, the leader in laboratory automation solutions for life science applications, announced today that it has selected Tekon Biotech Ltd., a leading full-service distributor to analytical and research laboratories, as exclusive distributor of its uniquely modular automation technologies to the top laboratories of China, Hong Kong and Taiwan.
Human Genome Sciences announced that BENLYSTA™ met the primary endpoint in BLISS-52, the first of two pivotal Phase 3 trials in patients with serologically active systemic lupus erythematosus (SLE). These results show that BENLYSTA™ has the potential to become the first new approved drug in decades giving hope to people living with systemic lupus.
Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTPD), today announced the appointment of Llew Keltner, M.D., Ph.D., to the Company's board of directors. Dr. Keltner is currently CEO and President of Light Sciences Oncology, a privately-held biotechnology company developing a late-stage, light-activated therapy for hepatocellular cancer and other solid tumors.
Nutritionists have since joined with manufacturers to produce supplements using fermentation from this rare mushroom. One such product is CordyMax®, made with a formula recognized in China as the fermented Cordyceps mushroom mycelial product. CordyMax® has been placed under intellectual property protection, and only one company has the license for it outside of China.
› Verified 2 days ago
Bayside Health And Rehabilitation Center Location: 4343 Langley Avenue, Pensacola, Florida 32504 Phone: (850) 477-4550 | |
Willowbrooke Court At Azalea Trace Location: 10100 Hillview Dr, Pensacola, Florida 32514 Phone: (850) 478-5200 | |
University Hills Health And Rehabilitation Location: 10040 Hillview Road, Pensacola, Florida 32514 Phone: (850) 474-0570 | |
Arcadia Health & Rehabilitation Center Location: 10095 Hillview Road, Pensacola, Florida 32514 Phone: (850) 479-4000 | |
Solaris Healthcare Pensacola Location: 8475 University Parkway, Pensacola, Florida 32514 Phone: (850) 474-1252 | |
Rehabilitation Center At Park Place Location: 1717 W Avery St, Pensacola, Florida 32501 Phone: (850) 434-2355 |